Castleview Partners, LLC Portfolio
Auto-discovered active 13F filer.
SEC 13F CIK: 0001737088
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2026 · 223 positions · Total reported value $227.52M · Top-10 concentration 34.5% · Updated 2026-10-24
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
Turnover: 40.8% · 17 new · 55 cut · 26 exited
Active Share (vs S&P 500): 78.8% · vs QQQ: 87.1% — share of the book that differs from index weights (higher = more active) · ranking
In its Q2 2026 13F filing, Castleview Partners, LLC disclosed 223 equity positions with a combined reported value of $227.52M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 34.5% of reported value. HoldingsHub classifies the profile as Small / High Turnover.
The largest disclosed positions as of Q2 2026 were MBSF ($25.39M), MBSX ($9.02M), TSLA ($7.31M). By sector, the heaviest allocations are Health Care 9.7%, Technology 9.5%. Versus the prior quarter, allocation shifted toward Health Care (+1.4pp), Utilities (+1.4pp) and away from Consumer Discretionary (-0.6pp), Consumer Staples (-1.5pp).
Versus the prior quarter, Castleview Partners, LLC opened 17 new positions, trimmed 55 and fully exited 26, a turnover rate of 40.8% of positions. The portfolio's overlap with the prior quarter was 69% of names.
The largest new positions opened in Q2 2026 were STAX ($5.68M), SYK ($2.62M), ITOT ($2.01M).
Of the 26 positions fully exited versus the prior quarter, the largest were FDVV ($2.98M), VBIL ($1.74M), SIVR ($1.63M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2026)
Fully Exited (vs previous quarter)
- FDVV FIDELITY COVINGTON TRUST · prev qtr: $2.98M
- VBIL VANGUARD INSTL INDEX FD · prev qtr: $1.74M
- SIVR ABRDN PHYSICAL · prev qtr: $1.63M
- VUG VANGUARD INDEX FDS · prev qtr: $631.16K
- ROST ROSS STORES INC · prev qtr: $596.17K
- CMI CUMMINS INC · prev qtr: $499.82K
- SGOL ABERDEEN STD GOLD ETF TR PHYSICAL SWISS GOLD SHS ETF · prev qtr: $408.14K
- ZTS ZOETIS INC · prev qtr: $366.21K
Insider Transactions (Form 4)
Latest Castleview Partners, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Castleview Partners, LLC, based in Dallas, TX, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q3 2026) lists 214 positions worth $228.19M in total. HoldingsHub carries 13 quarters of its filings (Q3 2023–Q3 2026).
Firm Snapshot
- Headquarters: DALLAS, TX, United States
- SEC registration: 801-106652 (status: Approved), registered 2015-09-11
- Regulatory AUM (Form ADV): $413.03M as of 2026-05-06
- Client mix (by RAUM): individual investors 81%, pooled investment vehicles 19%
- Website: castleviewpartners.com
Portfolio Structure
- 214 positions · $228.19M reported value (Q3 2026)
- Top 10 holdings = 34.6% of reported value
- Largest position: MBSF (VALUED ADVISERS TR) at 10.6%
- Average position size: $1.07M
Sector Tilt
- Health Care 10.6%
- Financials 8.7%
- Information Technology 8.1%
- (classified holdings cover 49% of value)
Quarterly Activity
- Q3 2026: 17 new, 111 added, 55 reduced, 26 exited
- 31 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
989.00K | $25.39M | 11.16% | Hold | |
| 2 |
|
330.18K | $9.02M | 3.96% | Add | |
| 3 |
|
17.37K | $7.31M | 3.21% | Add | |
| 4 |
|
23.99K | $6.94M | 3.05% | Reduce | |
| 5 |
|
223.41K | $5.68M | 2.50% | New | |
| 6 |
|
13.89K | $4.90M | 2.15% | Add | |
| 7 |
|
47.13K | $4.90M | 2.15% | Reduce | |
| 8 |
|
104.52K | $4.88M | 2.15% | Reduce | |
| 9 |
|
83.53K | $4.81M | 2.12% | Add | |
| 10 |
|
6.35K | $4.74M | 2.08% | Hold | |
| 11 |
|
47.97K | $4.40M | 1.94% | Add | |
| 12 |
|
10.55K | $3.82M | 1.68% | Add | |
| 13 |
|
117.31K | $3.81M | 1.67% | Reduce | |
| 14 |
|
8.89K | $3.69M | 1.62% | Reduce | |
| 15 |
|
29.89K | $2.89M | 1.27% | Add | |
| 16 |
|
8.33K | $2.62M | 1.15% | New | |
| 17 |
|
3.62K | $2.49M | 1.09% | Add | |
| 18 |
|
487.96K | $2.43M | 1.07% | Add | |
| 19 |
|
45.49K | $2.32M | 1.02% | Add | |
| 20 |
|
44.19K | $2.23M | 0.98% | Reduce | |
| 21 |
|
56.09K | $2.23M | 0.98% | Reduce | |
| 22 |
|
12.23K | $2.01M | 0.88% | New | |
| 23 |
|
49.20K | $1.90M | 0.83% | Add | |
| 24 |
|
9.15K | $1.83M | 0.80% | Reduce | |
| 25 |
|
4.70K | $1.82M | 0.80% | Reduce | |
| 26 |
|
34.66K | $1.65M | 0.73% | Reduce | |
| 27 |
|
4.28K | $1.60M | 0.70% | Add | |
| 28 |
|
1.11M | $1.59M | 0.70% | Add | |
| 29 |
|
6.51K | $1.55M | 0.68% | Add | |
| 30 |
|
11.13K | $1.52M | 0.67% | Reduce | |
| 31 |
|
32.29K | $1.51M | 0.66% | Reduce | |
| 32 |
|
15.96K | $1.46M | 0.64% | Add | |
| 33 |
|
4.02K | $1.42M | 0.62% | Add | |
| 34 |
|
3.76K | $1.42M | 0.62% | Add | |
| 35 |
|
59.71K | $1.41M | 0.62% | Reduce | |
| 36 |
|
25.53K | $1.31M | 0.58% | Hold | |
| 37 |
|
34.94K | $1.28M | 0.56% | Add | |
| 38 |
|
3.61K | $1.24M | 0.54% | Hold | |
| 39 |
|
23.68K | $1.23M | 0.54% | Hold | |
| 40 |
|
2.54K | $1.21M | 0.53% | Add | |
| 41 |
|
56.50K | $1.17M | 0.52% | Add | |
| 42 |
|
31.68K | $1.16M | 0.51% | New | |
| 43 |
|
33.84K | $1.16M | 0.51% | New | |
| 44 |
|
9.19K | $1.14M | 0.50% | Add | |
| 45 |
|
17.27K | $1.14M | 0.50% | Add | |
| 46 |
|
2.14K | $1.10M | 0.48% | Add | |
| 47 |
|
909 | $1.09M | 0.48% | Add | |
| 48 |
|
7.21K | $1.06M | 0.46% | Add | |
| 49 |
|
4.04K | $1.03M | 0.45% | Add | |
| 50 |
|
3.12K | $1.02M | 0.45% | Add | |
FAQ
What did Castleview Partners, LLC buy in 2026-Q2?
In its 2026-Q2 13F filing, Castleview Partners, LLC reported 223 equity positions worth $227.52M in aggregate; its largest disclosed positions were MBSF ($25.39M), MBSX ($9.02M), TSLA ($7.31M).
How large is Castleview Partners, LLC's portfolio?
Castleview Partners, LLC reported $227.52M of long equity holdings across 223 positions as of 2026-Q2. Top-10 holdings account for 34.5% of reported value.
What is Castleview Partners, LLC's investment style?
HoldingsHub classifies the portfolio as Small / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.